PRPH ProPhase Labs, Inc.
Healthcare$0.11+22.22%ClosedMarket Cap: $521,071
As of 2026-05-25
Insider Statistics (Q3 2025)
Acquisitions
1
Dispositions
0
Buy/Sell Ratio
0.00
Net Shares
+500,000
Shares Acquired
500,000
Shares Disposed
0
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Nov 10 | Abenante Carolina | director: | Sell | 0 | $0.00 | 0 |
| Thu Sep 11 | Karkus Ted William | director, officer: CEO & CHAIRMAN | Sell | 500,000 | $0.60 | 500,000 |
| Fri Feb 21 | Hollenshead Stuart | officer: Chief Operating Officer | Sell | 500,000 | $0.60 | 500,000 |
| Fri Feb 21 | Hollenshead Stuart | officer | Sell | 0 | $0.00 | 0 |
| Tue Feb 18 | Hirsch Warren | director | Sell | 100,000 | $0.60 | 100,000 |
| Tue Feb 18 | GLECKEL LOUIS MD | director | Sell | 100,000 | $0.60 | 100,000 |
| Thu Mar 21 | Karkus Ted William | director, 10 percent owner, officer: CEO & CHAIRMAN | Sell | 400,000 | $6.00 | 400,000 |
| Tue Mar 19 | Latkin Jed | director | Sell | 500,000 | $6.00 | 500,000 |
| Tue Mar 19 | Latkin Jed | officer | Sell | 0 | $0.00 | 0 |
| Tue Mar 19 | Hirsch Warren | director | Sell | 70,000 | $6.00 | 70,000 |